Topics:

Acne

Cosmetic

Eczema

Infections

Pediatric

Practice Management

Psoriasis

Residents

Rosacea

Skin Cancer

Skin of Color

Topic: Psoriasis

Hype v. Hope: Cannabinoids in Dermatology thumbnail

Hype v. Hope: Cannabinoids in Dermatology

Series: ASDS Annual Meeting 2019 | October 27, 2019

Integrative dermatology is growing, along with interest in the potential use of cannabinoids in dermatology. Peter Lio, MD addresses the science and the limitations of CBD.

Watch Video

News | October 18, 2019

UCB Presents New Data for Cimzia, Investigational Bimekizumab

Data on the use of UCB’s Cimzia (certolizumab pegol), in psoriasis and psoriatic arthritis (PsA) as well as Phase 2 data for the company’s investigational molecule bimekizumab have been presented at the 28thEuropean Academy of...

Read More

News | October 18, 2019

Data Show Long-term Benefit for Sun Pharma's Ilumya

Long-term follow-up data from ILUMYA® (tildrakizumab-asmn) Phase 3 reSURFACE 1 and 2 trials showed that the significant response rates seen in the initial 52 and 64 weeks, respectively, were maintained over four years for people...

Read More

News | October 18, 2019

Lilly: New Data for Treatment of Complex Dermatological Conditions at EADV, Maui Derm NP+PA

New data for Eli Lilly and Company’s Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab have been presented at the 28th annual European Academy of Dermatology and Venereology (EADV)...

Read More

New Evidence for Psoriasis Seasonality

There may indeed be a seasonality to psoriasis—if trends in online searches about the disease are an indication. Researchers analyzed relative search volume for psoriasis and related terms in Google Trends from January 2004 to...

Read Article

The Latest in Psoriasis

Post-Market Price Changes Alone Account for Most Recent Spending Growth for Biologics, and Rebates Have Little Impact image

News | November 10, 2019

Post-Market Price Changes Alone Account for Most Recent Spending Growth for Biologics, and Rebates Have Little Impact

News | November 10, 2019

Live Zoster Vaccine Safe and Effective for Patients on TNF Blockers

Clinical Focus Department Img

Clinical Focus | November 2019

Understanding a New Method of Assessing Psoriasis Severity

New method aims to improve access to systemic psoriasis therapy.

Jennifer Soung, MD

Oncology Watch Department Img

Oncology Watch | November 2019

Psoriasis and Cancer: Is There a Link?

New data adds to the evidence for a link between psoriasis and certain cancers, including skin cancer.

Jonathan Wolfe, MD

News Department Img

News | November 2019

Recent Developments

News | November 5, 2019

New AAD/NPF Guidelines Address Care for Pediatric Psoriasis

News | October 30, 2019

AbbVie Launches “Let Me Be Clear” to Urge Psoriasis Patients to Speak Up

Good Oral Health and Diet May Improve Psoriasis image

News | October 29, 2019

Good Oral Health and Diet May Improve Psoriasis

Hype v. Hope: Cannabinoids in Dermatology thumbnail

VIDEO | October 27, 2019

Hype v. Hope: Cannabinoids in Dermatology

Meeting Coverage | ASDS Annual Meeting 2019

Chicago, IL: October 24 - 27, 2019

Peter A. Lio, MD; and Joel L. Cohen, MD, FAAD

News | October 24, 2019

Arcutis Biotherapeutics Plans to Initiate Phase 3 Program for ARQ-151 for Plaque Psoriasis

News | October 18, 2019

UCB Presents New Data for Cimzia, Investigational Bimekizumab

Data Show Long-term Benefit for Sun Pharma's Ilumya image

News | October 18, 2019

Data Show Long-term Benefit for Sun Pharma's Ilumya

Data Show Long-term Benefit with Sun Pharma's Ilumya image

News | October 18, 2019

Data Show Long-term Benefit with Sun Pharma's Ilumya

News | October 18, 2019

Lilly: New Data for Treatment of Complex Dermatological Conditions at EADV, Maui Derm NP+PA

Cover Focus Department Img

Feature | October 2019

What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis

Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.

Jerry Bagel, MD, FAAD; Ted Lain, MD, MBA; and Lawrence J. Green, MD

Article | September 2019

New Evidence for Psoriasis Seasonality

Article | September 2019

Assessing Comorbidities in Psoriasis Patients: Key to Comprehensive Care

International Council Of Dermatologists Introduces New Method Of Determining Psoriasis Severity image

News | September 23, 2019

International Council Of Dermatologists Introduces New Method Of Determining Psoriasis Severity

News | September 13, 2019

Study: Long-Term Use of Brodalumab Is Safe, Effective

Increased Adherence, Symptom Improvement Seen when Psoriasis patients switch to IL-17 Blockers image

News | September 11, 2019

Increased Adherence, Symptom Improvement Seen When Psoriasis Patients Switch to IL-17 Blockers

View more

Featured Video Series

La Roche-Posay Laboratoire Dermatologique

View More +

Meeting Coverage

ASDS 2019 Chicago Thumbnail

AAD 2019 Summer Thumbnail

AAD 2019 Thumbnail

IMCAS 2019 Thumbnail

ASDS 2018 Thumbnail

AAD 2018 Thumbnail

View More +